Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Individuals' Medical Histories Predicted by their Noncoding Genomes Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.'Molecular Movie' Opens Door to New Cancer Treatments An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.Custom Tuning Knobs to Turn Off Any Gene Factory managers can improve productivity by telling workers to speed up, slow down or stop doing tangential tasks while assembling widgets. Unfortunately for synthetic biologists attempting to produce pharmaceuticals, microbes don’t respond to direction like human personnel.Unique Mechanism for a High-Risk Leukemia Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.Genetically Mapping the Most Lethal E.Coli Strains New approach could lead to fewer deaths, and new treatments. The Spice of Life Scientists discover important genetic source of human diversity.Cytoskeleton Crew Findings confirm sugar's role in helping cancers survive by changing cellular architecture.Removing Race from Human Genetic Research A group of scientists are urging their colleagues to take a step forward and stop using racial categories when researching and studying human genetics. Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
Personalized Stem Cell Therapies for Tissue Regeneration Sheldon Schaffer, Vice President, Aastrom Biosciences, Speaking at Stem Cells World Congress 2010.
Double Knockdown of Transcription Factors DP1 and DP2 Revealed Their Unique Roles in the Regulation of Matrix Metalloproteinase as Well as Cell Cycle Progression Kenichi Yoshida, Associate Professor, Meiji University, speaking at European Biomarkers Summit 2009
Cancer Biomarkers for Diagnosis and Therapy Prediction Ralph Schiess, ETH, Researcher, speaking at Cancer Proteomics 2010.
Blood-Based Exopeptidase Activities as Biomarkers for Cancer Paul Tempst, Memorial Sloan-Kettering Cancer Center, Professor, speaking at Cancer Proteomics 2010.
Domain Antibody-Based Arrays for Breast Cancer Diagnostic Klervi Even, Inserm, speaking at Cancer Proteomics 2010.
Clinical Proteomics – Ready for Prime Time in Urological Cancer Diagnostics? Eric Schiffer, Mosaiques Diagnostics, Clinical Project Manager, speaking at Cancer Proteomics 2010.
Application of Profiling the Antibody Repertoire for Discovery of Cancer Biomarkers. Delores Cahill, University College Dublin, Professor, speaking at Cancer Proteomics 2010.
13CO2 a Biomarker in Breath for Individualized Cancer Therapy Anil Modak, Cambridge Isotope Laboratory, Associate Director, speaking at Cancer Proteomics 2010.